GlassScriptPhysician profile
Jarrod M Shapiro
NPI 1316964992
$4,001.42
in general payments reported to CMS, 2019-2025
25 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $258 · 2021: $133 · 2022: $1,892 · 2023: $234 · 2024: $194 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Empire Medical, INC | $1,200.00 | 2022 | |
| Stryker Corporation | $712.46 | 2019-2025 | Easyfuse, Augment Injectable, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $321.17 | 2023-2025 | |
| Biotissue Holdings INC. | $274.51 | 2022-2024 | |
| Smith+Nephew, INC. | $268.40 | 2019-2025 | Stravix, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Integra Lifesciences Corporation | $203.67 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $189.36 | 2019-2020 | |
| Ossio INC | $114.91 | 2022-2023 | |
| Wright Medical Technology, INC. | $103.64 | 2019-2020 | |
| Acumed LLC | $95.03 | 2019 | |
| Extremity Medical | $73.41 | 2019 | |
| Medtronic, INC. | $65.16 | 2022 | |
| Depuy Synthes Sales INC. | $57.86 | 2019 | |
| Organogenesis INC. | $42.92 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $37.12 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $36.36 | 2019-2025 | Nimbl, Flexitouch Plus |
| Djo, LLC | $29.36 | 2020 | |
| Averitas Pharma INC. | $26.47 | 2023 | Qutenza |
| Avanos Medical | $25.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $24.55 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $22.75 | 2023 | Krystexxa |
| Cardiovascular Systems INC. | $22.10 | 2021 | |
| Bsn Medical INC | $20.04 | 2025 | |
| Abbvie INC. | $17.61 | 2022 | |
| Becton, Dickinson and Company | $17.45 | 2024 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrod Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.